- increased bone mineral density / IMPC
- decreased bone mineral density / IMPC
- decreased circulating HDL cholesterol level / IMPC
- increased circulating calcium level / IMPC
- decreased body weight / IMPC
- abnormal lens morphology / IMPC
- cataract / IMPC
- increased circulating free fatty acids level / IMPC
- abnormal vibrissa morphology / IMPC
- decreased circulating triglyceride level / IMPC
- decreased circulating free fatty acids level / IMPC
- decreased hemoglobin content / IMPC
- increased lactate dehydrogenase level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- increased lean body mass / IMPC
- abnormal behavior / IMPC
- decreased T cell number / IMPC
- decreased circulating cholesterol level / IMPC
- abnormal response to tactile stimuli / IMPC
- increased circulating aspartate transaminase level / IMPC
- decreased circulating serum albumin level / IMPC
- decreased blood urea nitrogen level / IMPC
- increased circulating total protein level / IMPC
- increased mature B cell number / IMPC
- decreased total body fat amount / IMPC
C57BL/6NTac-Arhgef4tm1a(KOMP)Wtsi/Wtsi
Status | Available to order |
EMMA ID | EM:12046 |
International strain name | C57BL/6NTac-Arhgef4tm1a(KOMP)Wtsi/Wtsi |
Alternative name | EPD0135_1_A05 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Arhgef4tm1a(KOMP)Wtsi |
Gene/Transgene symbol | Arhgef4 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from KOMP ES clone EPD0135_1_A05. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References |
|
Information from EMMA
Archiving centre | Wellcome Trust Sanger Institute, Hinxton, United Kingdom |
Animals used for archiving | homozygous C57BL/6N, wild-type C57BL/6N |
Stage of embryos | 2-cell |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- decreased circulating serum albumin level / IMPC
- cataract / IMPC
- decreased bone mineral density / IMPC
- increased lean body mass / IMPC
- increased lactate dehydrogenase level / IMPC
- increased circulating total protein level / IMPC
- abnormal lens morphology / IMPC
- decreased T cell number / IMPC
- increased circulating free fatty acids level / IMPC
- decreased blood urea nitrogen level / IMPC
- decreased hemoglobin content / IMPC
- decreased circulating HDL cholesterol level / IMPC
- increased circulating calcium level / IMPC
- decreased circulating free fatty acids level / IMPC
- decreased circulating cholesterol level / IMPC
- abnormal vibrissa morphology / IMPC
- abnormal response to tactile stimuli / IMPC
- abnormal behavior / IMPC
- increased mature B cell number / IMPC
- decreased total body fat amount / IMPC
- increased circulating alkaline phosphatase level / IMPC
- increased circulating aspartate transaminase level / IMPC
- decreased body weight / IMPC
- decreased circulating triglyceride level / IMPC
- increased bone mineral density / IMPC
Literature references
- Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes.;White Jacqueline K, Gerdin Anna-Karin, Karp Natasha A, Ryder Ed, Buljan Marija, Bussell James N, Salisbury Jennifer, Clare Simon, Ingham Neil J, Podrini Christine, Houghton Richard, Estabel Jeanne, Bottomley Joanna R, Melvin David G, Sunter David, Adams Niels C, null null, Tannahill David, Logan Darren W, Macarthur Daniel G, Flint Jonathan, Mahajan Vinit B, Tsang Stephen H, Smyth Ian, Watt Fiona M, Skarnes William C, Dougan Gordon, Adams David J, Ramirez-Solis Ramiro, Bradley Allan, Steel Karen P, ;2013;Cell;154;452-64; 23870131
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).